|
271 |
The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties
Enthalten in Psychotherapy and psychosomatics Bd. 92, 2024, Nr. 6: 359-366. 8 S.
|
|
|
|
272 |
Effects of Safinamide on Motor and Non-Motor Symptoms in Patients with Parkinson’s Disease and Motor Fluctuations
Enthalten in European neurology Bd. 87, 2024, Nr. 5-6: 291-305. 15 S.
|
|
|
|
273 |
Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson’s Disease: A Network Meta-Analysis
Enthalten in European neurology Bd. 87, 2024, Nr. 5-6: 273-290. 18 S.
|
|
|
|
274 |
Effects of Progesterone on Vasomotor Symptoms in Postmenopausal Women (PROGEST) – a Prospective Multi-Center Randomized Double-Blind Placebo-Controlled Trial (RDPCT)
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 10: 969-978
|
|
|
|
275 |
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial
Enthalten in Annals of nutrition & metabolism Bd. 79, 2024, Nr. 6: 522-527. 6 S.
|
|
|
|
276 |
The Impact of Omega-3 Polyunsaturated Fatty Acid Supplementation on Singing Training in Vocal Performers: A Non-Randomized Double-Blind Placebo-Controlled Study
Enthalten in Folia phoniatrica et logopaedica Bd. 76, 2024, Nr. 4: 352-365. 14 S.
|
|
|
|
277 |
Placebo und Nocebo in der Kommunikation – Eine systematische Literaturübersicht
Enthalten in Quintessenz Zahnmedizin Bd. 75, 2024, Nr. 7: 609-620
|
|
|
|
278 |
Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study
Enthalten in Drug research Bd. 74, 2024, Nr. 02: 53-59
|
|
|
|
279 |
Homöopathie und das vegetative Nervensystem – Grundlagen und Erfahrungen
Enthalten in Erfahrungsheilkunde Bd. 73, 2024, Nr. 06: 318-323
|
|
|
|
280 |
Bücher
Enthalten in Erfahrungsheilkunde Bd. 73, 2024, Nr. 02: 110-112
|
|
Administration
